Hvad er Org-nummeret på Sortina pharma AB?

Sortina pharma AB er registreret hos Bolagsverket / SCB under Org 5592354871.

Hvor mange medarbejdere har Sortina pharma AB?

Sortina pharma AB beskæftiger 1 personer pr. seneste årsrapport.

Sara Johanna Rost er administrerende direktør i Sortina pharma AB, i rollen siden 2023.

Sara Johanna Kristina Malcus er bestyrelsesformand i Sortina pharma AB, i rollen siden 2023.

Sortina pharma ABs registrerede adresse er Erik Dahlbergsgatan 11 A.

ABActive

Org 5592354871Erik Dahlbergsgatan 11 A, 411 26 GöteborgResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2020 · 6 years old1 employees

Aktivt ansatte i selskabet

Name	Role	Member since
Current (2)
SJ Sara Johanna Rost Chief Executive Officer	Chief Executive Officer	2023
KE Karin Elisabeth Hammarberg Audit	Audit	2023
Former (1)
ZM Zlatan Mitrovic Chief Auditor	Chief Auditor	2022 – 2023

Ikke-udøvende tilsyn

Name	Role	Member since
Current (5)
KÖ Klementina Österberg Deputy Board Member	Deputy Board Member	2023
PP Peter Prosper A. Suenaert Board of Directors	Board of Directors	2023
EC Eva Catharina Bäärnhielm Marklund Board of Directors	Board of Directors	2023
GL Göran Landberg Board of Directors	Board of Directors	2021
SJ Sara Johanna Kristina Malcus Chairman	Chairman	2023
Former (8)
MH M H Charlotte Wiberg Larsson Chairman	Chairman	2020 – 2021
PJ Per Jesper Dahlberg Deputy Board Member	Deputy Board Member	2021 – 2023
BT Bo Torsten Nilsson Board of Directors	Board of Directors	2020 – 2021
BA Bengt Anders Waas Chairman	Chairman	2021 – 2023
JR Jan Roland Pilebjer Board of Directors	Board of Directors	2021 – 2022
PJ Peter Jonas Michael Carlborg Deputy Board Member	Deputy Board Member	2020 – 2021
TI Tommy Ingemar Abrahamsson Board of Directors	Board of Directors	2022 – 2023
BT Bo Torsten Patrik Nilsson Deputy Board Member	Deputy Board Member	2020 – 2021

Pr. seneste årsrapport

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.